Adenosine Receptors Influence Ischemia-Reperfusion Injury

Status Suspended

Clinical Trial Summary

Ischemic preconditioning is defined as the development of tolerance to ischemia-reperfusion injury by a previous short bout of ischemia resulting in a marked reduction in infarct size. This mechanism can be mimicked by several pharmacological substances such as acetylcholine and adenosine.

To detect ischemia-reperfusion injury in humans in vivo Kharbanda et al. developed a method in which endothelial dysfunction represents the effects of ischemic preconditioning. This method, however, uses acetylcholine to measure endothelial function before and after forearm ischemia. We, the investigators at Radboud University, hypothesize that the use of acetylcholine in this model reduces ischemia-reperfusion injury. Therefore, we will compare this protocol with a protocol in which endothelial function is only measured after ischemia. We expect an increase in ischemia-reperfusion injury when endothelial function is only measured after the forearm ischemia.

After determining the optimal method to measure ischemia-reperfusion injury of the vascular endothelium we will determine the effect of acute and chronic caffeine, an adenosine receptor antagonist, on ischemic preconditioning. With this study we expect to find that adenosine mimics ischemic preconditioning of the vascular endothelium. Moreover, we expect to find that acute caffeine intake reduces ischemia-reperfusion injury whereas chronic caffeine intake does not. This study will increase our knowledge about the mechanism of ischemic preconditioning and may also provide leads to exploit this endogenous protective mechanism in a clinical setting.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double-Blind

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00184847
Study type	Interventional
Source	Radboud University
Contact
Status	Suspended
Phase	N/A
Start date	March 2005

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05327348` - Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery	Phase 3
Completed	`NCT00184912` - The Effect of Caffeine on Ischemic Preconditioning	N/A
Recruiting	`NCT05585255` - Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
Completed	`NCT05598177` - Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass	Phase 4
Completed	`NCT04284592` - Remote Ischemic Postconditioning Increases HIF-1α Plasma Levels and Improves Cardiac Markers After Cardiac Surgery	N/A
Withdrawn	`NCT00441714` - Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise	N/A
Completed	`NCT00248040` - Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation	Phase 2
Completed	`NCT01486212` - Ischemia-reperfusion Injury Model on Healthy Volunteers and Measurement of Oxidative and Inflammatory Markers	N/A
Recruiting	`NCT06097702` - A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants	Phase 1
Completed	`NCT01073202` - Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation	N/A
Completed	`NCT00224406` - Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation	Phase 2
Active, not recruiting	`NCT05246618` - FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation	Phase 1/Phase 2
Completed	`NCT02118753` - The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium	N/A
Completed	`NCT01739088` - Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery	N/A
Completed	`NCT01040013` - Gut Oxygenation and Laparoscopy	Phase 2
Completed	`NCT01172171` - The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction	Phase 2
Completed	`NCT00457405` - Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?	Phase 4
Completed	`NCT00184821` - Ischemic Injury and Ischemic Preconditioning in Diabetes	N/A
Not yet recruiting	`NCT00691613` - Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model	N/A
Completed	`NCT03818126` - The Del Nido Versus Cold Blood Cardioplegia in Aortic Valve Replacement	N/A